EP Wealth Advisors’s Erasca ERAS Stock Holding History

EP Wealth Advisors’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,000	Closed	-$112K	–	1526
2025 Q4	$112K	Buy	+30,000	New	+$84.4K	﹤0.01%	1447
2025 Q2	$29.2K	Buy	+23,000	New	+$30.8K	﹤0.01%	1415

Other funds holding ERAS

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

EP Wealth Advisors's ERAS Position: Q1 2026 in Review

EP Wealth Advisors sold out of Erasca (ERAS) in Q1 2026, closing a stake of 30,000 shares — an estimated $112K sold.

EP Wealth Advisors first reported a position in ERAS in Q2 2025 and held it in 2 quarters. The position peaked at $112K in Q4 2025. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

EP Wealth Advisors reported no remaining Erasca position as of Q1 2026 after selling out during the quarter.
EP Wealth Advisors sold 30,000 Erasca shares in Q1 2026, an estimated $112K.
EP Wealth Advisors first reported a position in Erasca in Q2 2025 and held it in 2 quarters.
EP Wealth Advisors's Erasca position peaked at $112K in Q4 2025.
225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on EP Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.